Twinbeech Capital LP Sarepta Therapeutics, Inc. Transaction History

Twinbeech Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $10.4 Million - $19.3 Million	154,788 New	154,788 $14.9 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $6.12 Million - $9.04 Million	-57,536 Reduced 40.88%	83,201 $9.53 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $16.1 Million - $21.4 Million	137,084 Added 3752.64%	140,737 $19.4 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $368,441 - $482,670	3,653 New	3,653 $473,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $900,103 - $1.27 Million	-14,358 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $906,707 - $1.3 Million	14,358 New	14,358 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $1.53 Million - $2.14 Million	-23,155 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $943,914 - $1.18 Million	13,605 Added 142.46%	23,155 $1.8 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $689,987 - $1.61 Million	9,550 New	9,550 $712,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.